Legitimacy & Accreditation
Whether the provider is a real, accountable operation — accredited, licensed to prescribe in the states it serves, and transparent about who it actually is.
Why it matters
This is the floor. A telehealth brand that will not name its corporate identity, licensing, or pharmacy partners is asking you to hand over your health and your money on trust alone — and impersonator sites trade on exactly that ambiguity.
How we assess it
We check the trust infrastructure a legitimate operator can show and a fly-by-night one cannot.
- Accreditation status and third-party trust certifications
- Whether an accreditation seal is displayed on the provider’s own site — recorded as a display fact carrying the date it was read
- State pharmacy / medical licensure for the states served
- A transparent, verifiable corporate identity
- Review volume as a proxy for real operating history
- A check for impersonator or look-alike sites trading on the brand
Source types: Accreditation and licensing bodies — LegitScript, NABP (including its .pharmacy verification), URAC — plus state licensing registries and the provider’s own corporate disclosures. On LegitScript specifically, what we read is the provider’s own website and never LegitScript’s register: their terms do not permit automated queries to it, so we do not query it and we do not report what it says. A LegitScript-issued seal asset found on a provider’s own pages — its seal ID recorded, its display re-checked at the time of each scan — therefore establishes SEAL DISPLAY: that this provider showed this seal ID on these pages on that date. It does not establish current certification. Whether a certification is live is a fact held on LegitScript’s register, and we do not read that register, so we cannot report it. Display is a fact about the provider’s page on a date, not about the provider’s standing. A display reading expires, and that is part of this rule rather than a caveat to it: a provider in our own corpus removed its LegitScript widget between two of our scans, so an earlier reading is not evidence about today. We re-scan and cite the fresh reading; a stale display reading establishes nothing. Absence works in one direction only. No seal found is not evidence of no certification — displaying one is not required — so a provider without one is recorded as unresolved on this signal and never penalised for it, and we state which pages were searched.
How we score it
Verified accreditation, clear licensure, and a transparent identity score high. Missing accreditation, opacity about who runs the site, or an active impersonation problem is the red flag this factor exists to catch, and pulls the subscore down hard. A displayed seal does not on its own resolve this factor, and that limit is deliberate. A badge on a provider’s own page is the provider attesting to its own accreditation, and this factor exists to ask whether an independent body has verified it — so seal display is recorded as a company-attested claim and lifts no subscore by itself. Resolving this factor needs evidence about licensure and corporate identity that does not rest on the provider’s own badge.
- Importance
- Critical
Critical — the most heavily weighted tier. A provider that fails legitimacy cannot rank well no matter how good its prices look. In ED, where counterfeit-pill risk is acute, we treat it as even more decisive.
- Scope
- Universal — applies to every provider
What this tier is worth
What strong vs weak looks like
Strong
An independent body’s record — not the provider’s own badge — establishes accreditation, with licensure evidenced in the states it ships to and corporate ownership stated plainly.
Weak
No accreditation we can establish from any source but the provider itself, an anonymous operator, and look-alike domains competing for the same searches.
Not medical advice
- Scope
- Universal — applies to every provider
- Standard reference
- LegitScript / NABP / URAC
How this shows up in real reviews
Cited evidence we captured on this factor in live provider reviews.
- SkinnyRx
Real operating US telehealth entity (Lean Rx, Inc.). FDA reviewed skinnyrx.com in December 2025 and found the site represented SkinnyRx as the compounder of its semaglutide and tirzepatide products when it is not, issuing a February 2026 misbranding warning letter. BBB rates it B and it is not accredited.
- MEDVi
MEDVi says its compounded medications are prepared by Belmar Pharma Solutions. The accreditations Belmar lists on its own site could not be checked against the issuing registers, so they are company-attested rather than independently confirmed. A February 2026 FDA warning letter cited MEDVi for misbranding.